HIGHLIGHTS
- who: BPB Reports from the aDepartment of Gastroenterological Surgery, Hyogo Medical University, Hyogo, Japan have published the research: BPB Reports, in the Journal: (JOURNAL)
- what: The experiment showed that HET treatment might reduce lenvatinib-induced chronic fatigue in mice.
- future: The effect of HET treatment on symptoms including fatigue may be associated with downregulation of IL-6 expression through NF-u03baB inhibition however further research is required to confirm this BPB Reports hypothesis. Studies are required to determine whether administering HET specifically benefits lenvatinib-induced chronic fatigue in mice with HCC.
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.